| __timestamp | Dr. Reddy's Laboratories Limited | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 1213000 |
| Thursday, January 1, 2015 | 42585000000 | 3425000 |
| Friday, January 1, 2016 | 45702000000 | 6311000 |
| Sunday, January 1, 2017 | 46372000000 | 9518000 |
| Monday, January 1, 2018 | 46910000000 | 28080000 |
| Tuesday, January 1, 2019 | 48890000000 | 36550000 |
| Wednesday, January 1, 2020 | 50129000000 | 46125000 |
| Friday, January 1, 2021 | 54559000000 | 68486000 |
| Saturday, January 1, 2022 | 62081000000 | 92032000 |
| Sunday, January 1, 2023 | 105931000000 | 117532000 |
| Monday, January 1, 2024 | 77201000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc. offer a fascinating study in contrasts. Over the past decade, Dr. Reddy's has consistently maintained higher SG&A expenses, peaking at over 100% more than Rhythm Pharmaceuticals in 2023. However, this isn't necessarily a negative indicator. Dr. Reddy's, a well-established player, has a broader operational scope, justifying its higher expenses. In contrast, Rhythm Pharmaceuticals, a smaller entity, has shown a steady increase in SG&A costs, reflecting its growth trajectory. Notably, data for 2024 is incomplete, highlighting the dynamic nature of financial reporting. This comparison underscores the importance of context in financial analysis, where size, market presence, and growth stage significantly influence cost structures.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Rhythm Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and Rhythm Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared